Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2001-8-14
pubmed:abstractText
The efficacy of 20(S)-camptothecin (CPT), free and incorporated into sterically stabilized liposomes, has been investigated in vitro against Leishmania donovani promastigotes and in vivo in a murine model of visceral leishmaniasis. Incubation of L. donovani promastigotes with free or liposomal CPT inhibited the growth of parasites in a dose-dependent manner. Tissue distribution studies revealed that the intraperitoneal administration of liposomal CPT was efficient for the delivery of high drug levels to the liver and spleen. Treatment of infected mice with intraperitoneal injections of free and liposomal CPT significantly reduced the parasite loads in the livers by 43 and 55%, respectively, compared with the loads for untreated controls. However, both treatments caused normochromic anemia and neutropenia.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-10228071, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-11018661, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-1335513, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-1371411, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-15463585, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-1778888, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-1890605, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-3182827, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-3804446, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-7546414, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-7561203, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-7759766, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-8334142, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-8499440, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9332461, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9333030, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9593743, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9619864, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9702210, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9769017, http://linkedlifedata.com/resource/pubmed/commentcorrection/11502539-9855627
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2623-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin.
pubmed:affiliation
Centre de Recherche en Infectiologie, Université Laval, Québec, Québec, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't